Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
25.14
-1.19 (-4.52%)
At close: Apr 28, 2026, 4:00 PM EDT
25.17
+0.03 (0.12%)
After-hours: Apr 28, 2026, 5:28 PM EDT
Tango Therapeutics Employees
Tango Therapeutics had 137 employees as of December 31, 2025. The number of employees decreased by 18 or -11.61% compared to the previous year.
Employees
137
Change (1Y)
-18
Growth (1Y)
-11.61%
Revenue / Employee
$455,358
Profits / Employee
-$741,562
Market Cap
3.63B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Travere Therapeutics | 497 |
| Structure Therapeutics | 220 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 146 |
TNGX News
- 13 days ago - Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat - GlobeNewsWire
- 6 weeks ago - Tango Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Tango Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Tango Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts
- 3 months ago - Tango Therapeutics Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor - GlobeNewsWire
- 4 months ago - Tango Therapeutics Appoints Sung Lee to Board of Directors - GlobeNewsWire
- 4 months ago - Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire